|
NRG Oncology Memo: Cisplatin & Carboplatin Shortages
Please review the memorandum (posted on the NRG Oncology website) for recommended strategies for enrolling participants in NRG trials involving Cisplatin and Carboplatin.
OTHER PROTOCOL NOTICES
1. ALL DISEASE SITES
NRG-GY022: Reminder: Actively Recruiting MALE Patients only Read More
2. BRAIN
NRG-BN009: An updated funding sheet is posted on CTSU.
3. CANCER PREVENTION & CONTROL
NRG-CC005/FORTE: New and revised patient-directed materials are now available under the CIRB tab on the CTSU website for NRG-CC005. Please see the memorandum posted on CTSU for more information about these materials.
NRG-CC005/FORTE: The patient study web page has been updated and is available on the NRG Oncology website.
4. GYNECOLOGIC
GOG-0210: Reminder: Biospecimens, biomarker data, clinical data, and epidemiologic data are available for request. Please visit the NRG Oncology website for more information on this important study with the overall goal of improving the outcome and/or quality of life for patients with endometrial cancer.
NRG-GY012: Nearing accrual. Accrual is currently at 285 of the planned 288 patients. Please plan accordingly and check CTSU before enrolling patients.
NRG-GY012 and NRG-GY023 – Reminder: BLOOD PRESSURE CUFF SUPPLY IS VERY LIMITED - Please be advised that VWR has a very limited supply of blood pressure cuffs at present. Please check your supplies on site for any overlooked cuffs prior to ordering. Thank you for your cooperation.
NRG-GY020: Reminder that there are mandatory biospecimen submissions at recurrence. Please review protocol Section 10.5.1 and Appendix V for complete information.
Printing Biospecimen Transmittal PDFs on GYN Trials
Please note an effort is underway to clarify how to obtain a Biospecimen Transmittal PDF for submission to the NRG Oncology Biospecimen Bank. Read More
5. HEAD & NECK
NRG-HN005: Sites in Canada only: The NOL and additional forms for amendment 3 are posted on CTSU. Please complete and submit the CTSI, Protocol signature page and IB signature page via the Regulatory submission portal.
NRG-HN008: Reminder -Please update treatment and AE data weekly. This is a Phase I trial and timely data submission is very important.
6. LUNG
NRG-LU008: Sites in Canada only: The NOL and additional forms for this study are posted on CTSU. Please complete and submit the CTSI, Protocol signature page and IB signature page via the Regulatory submission portal.
7. VTOC TRAINING
The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, NRG-CC005, and NRG/SWOG S1914. Space is limited so register now and reserve your seat. The next webinar training is scheduled for Wednesday, July 12, 2023.
|